Question Bank › Ahead of their own clock

Ahead of their own clock

Ahead of their own clock: a consequential milestone just moved earlier than the company's own prior timeline

Calls Tested
496
Answered YES
17
Hit Rate
3.4%
rare by design

Coterra Energy Inc. (CTRA) — this company's answers

NO on the Q1 2024 call 2024-05-03 A
The model's full reasoning — Q1 2024 call → NO我们根据指令,需要判断管理层是否在电话会议中明确表示某个重要的里程碑比公司自己之前沟通或假设的时间表更早或更快地发生。关键是要找到管理层自己的话,描述一个具体的、可识别的步骤(如设施、产品、项目等)提前于计划、比预期更快等。 浏览整个电话会议记录。管理层提到了许多运营效率提升、成本降低、产量超预期等。但我们需要寻找一个具体的里程碑,比如某个项目、设施、产能上线等,被描述为提前于公司自己的时间表。 在记录中,关于Windham Row项目,Blake提到“Our Windham Row project is off and running with 34 wells now drilled and our simul-frac operations underway.” 这似乎是一个正在进行的项目,但没有明确说比计划提前。关于simul-frac,他说“We are seeing encouraging initial performance from our simul-frac crew with an increase of 1,000 completed feet per day versus our normal zipper performance with a decreased cost of $25 per foot.” 这说的是性能提升,但不是时间提前。 关于Permian的产量,Shane说“oil production came in at 102.5 thousand barrels of oil per day above the high end of our guidance” 这是财务/运营结果超预期,但不是里程碑提前。 关于Marcellus的延迟,那是推迟,不是提前。 关于资本支出,说“capital expenditures came in at $450 million, which was below the guidance range” 这是低于预期,不是提前。 有没有提到某个项目提前完成?例如,关于Windham Row,说“we were able to fit these three new wells to our existing schedule without incurring additional facility or infrastructure costs.” 这说的是增加井数但不影响时间表,不是提前。 关于simul-frac,说“Our electric simul-frac crew is powered directly off our Coterra-owned grid with no generation in the field required.” 这是描述,没有时间提前。 关于Anadarko,说“We are in the middle of a large block of completion activity” 没有提前。 关于Marcellus,说“we have chosen to delay a portion of our well head compression program into 2025” 这是推迟。 关于债券发行,说“we successfully issued Coterra's inaugural bond offering” 这是完成,但没有说提前。 关于股东回报,没有。 所以,没有明确的管理层陈述说某个里程碑比公司自己之前的时间表更早。所有“ahead”的语言都是关于财务结果或产量超预期,而不是关于一个具体的运营里程碑提前。 因此,答案应为NO。

← Back to the full CTRA analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management state that a CONSEQUENTIAL upcoming milestone for the company is now happening EARLIER or FASTER than the company's OWN previously communicated or previously assumed timeline — that is, management compares progress against the schedule the company itself had set and reports that the schedule has moved in the company's favor, with the milestone now near at hand? Answer YES when management's own words convey, in whatever form fits the business, this ONE phenomenon: a specific, identifiable step that matters to the company's future size or earnings — such as a facility, plant, mine, store rollout, or capacity coming online; a product, program, or service launching or shipping; a ramp reaching its target level; a contract, integration, conversion, or expansion completing; a certification, approval, qualification, or start-up being reached; or a turnaround or build phase finishing — is described as running AHEAD OF SCHEDULE, arriving SOONER THAN PLANNED, being PULLED FORWARD, or progressing FASTER THAN THE COMPANY ITSELF EXPECTED, with the earlier timing presented as management's own current expectation grounded in real progress already made (work completed, stages passed, early output or activity already occurring). The milestone should be near-dated — expected to land within roughly the next year — and management should treat it as consequential to the company's trajectory rather than a minor operational detail. Answer NO if the only "ahead of expectations" language refers to reported financial results beating guidance or consensus, with no operational milestone moving earlier in time. NO if management merely reaffirms that something remains "on track" or "on schedule" without the timing improving. NO if the acceleration is hoped for, targeted, or conditional rather than management's stated current expectation backed by progress already made. NO if the milestone is trivial or routine for this company, or so distant that its arrival falls well beyond the coming year. NO if management is explaining delays, slippage, or a schedule that moved later, even alongside positive spin. NO if the earlier timing is suggested only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
TEL TE Connectivity Ltd. Q4 2023 2023-11-01 B
INGN Inogen, Inc. Q1 2023 2023-05-05 F
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
HLIO Helios Technologies, Inc. Q1 2022 2022-05-10 C
ADSE ADS-TEC Energy PLC Q4 2021 2022-04-28 D
ZENV Zenvia Inc. Q4 2021 2022-03-17 C+
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
WMB The Williams Companies, Inc. Q3 2021 2021-11-02 B
CLVT Clarivate Plc Q2 2021 2021-07-31 B+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
T AT&T Inc. Q3 2018 2018-10-24 C+
JBT John Bean Technologies Corporation Q2 2018 2018-07-26 B
AOSL Alpha and Omega Semiconductor Limited Q2 2018 2018-02-07 B
BCE BCE Inc. Q2 2017 2017-08-05 B+
WYY WidePoint Corporation Q3 2016 2016-11-09 D
ARKR Ark Restaurants Corp. Q1 2016 2016-05-13 B
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A

How the model reasoned

HLIO · Q1 2022 → YESThe question is: Does management state that a CONSEQUENTIAL upcoming milestone for the company is now happening EARLIER or FASTER than the company's OWN previously communicated or previously assumed t...YES The transcript shows management explicitly stating they are "on track to achieve the milestone that we have accelerated by two years of reaching at least $1 billion in revenue by 2023." This is presented as management's current expectation based on progress already made, with the $1B revenue target now arriving two years earlier than 2025. The milestone is consequential to the company's future size and earnings trajectory, and it is near at hand (within the next year). This matches the criteria for an accelerated timeline driven by real operational progress. The answer is YES.
AGIO · Q3 2018 → YESThe question is: Does management state that a CONSEQUENTIAL upcoming milestone is now happening EARLIER or FASTER than the company's OWN previously communicated timeline? **YES** Management explicitly states that the sNDA submission for ivosidenib in newly diagnosed AML patients ineligible for standard therapies is now planned for the end of January 2019, following acceleration of the frontline strategy. This is presented as a direct result of FDA discussions and Real-Time Oncology Review participation, with the 34-patient cohort data already generated and accepted into the pilot program. The timing is framed as an improvement over prior expectations, making the milestone (submission of the application) imminent and consequential for expanding TIBSOVO access.
ESE · Q2 2016 → YESThe question is: Does management state that a CONSEQUENTIAL upcoming milestone is now happening EARLIER or FASTER than the company's OWN previously communicated timeline? YES The transcript shows management explicitly stating that the restructuring actions (a key cost-reduction milestone tied to future earnings and operational focus) are "running ahead of schedule" and "progressing ahead of schedule," with completion expected to eliminate management distraction and deliver anticipated benefits sooner than previously planned.

More from the question bank

Correcting the record with current factsReordering the pecking orderSomeone else already paid for the growthAlready spoken for downstreamScarcity premium: the thing the company sellPaid-in full, payoff just startingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.